Lead Product(s) : Afimoxifene
Therapeutic Area : Undisclosed
Study Phase : Phase III
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Trial of 4-Hydroxytamoxifen (4-OHT) Gel in Women Aimed at Reducing Dense Breast Tissue
Details : 4-OH tamoxifen is a drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of undefined medical condition.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
June 27, 2017
Lead Product(s) : Afimoxifene
Therapeutic Area : Undisclosed
Highest Development Status : Phase III
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Afimoxifene
Therapeutic Area : Oncology
Study Phase : Phase II
Sponsor : National Cancer Institute | BHR Pharma
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Afimoxifene is a Other Small Molecule drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Carcinoma, Intraductal, Noninfiltrating.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
December 15, 2016
Lead Product(s) : Afimoxifene
Therapeutic Area : Oncology
Highest Development Status : Phase II
Sponsor : National Cancer Institute | BHR Pharma
Deal Size : Inapplicable
Deal Type : Inapplicable